Based on these findings, we hypothesized that the protective role of the CB2 receptor against myocardial fibrosis may be associated with the modulation of the Nrf2–TGβ1–Smad3 complex pathway in cardiomyocytes (Figure 1). The gene discussed is SMAD3; the disease is Myocardial fibrosis.